Can financial engineering cure cancer?

American Economic Review

Volumn 103, Issue 3, 2013, Pages 406-411

  Fagnan, David E ^a   Fernandez, Jose Maria ^a   Lo, Andrew W ^b   Stein, Roger M ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879109143     PISSN: 00028282     EISSN: None     Source Type: Journal    
DOI: 10.1257/aer.103.3.406     Document Type: Conference Paper

References (15)

1. American Cancer Society. 2011. Cancer Facts & Figures 2011. Atlanta, GA: American Cancer Society.
2. Evaluate Pharma. 2010. World Preview 2016. London: Evaluate Pharma.
3. Fagnan, David, Jose Maria Fernandez, Andrew W. Lo, and Roger M. Stein. 2013. "Can Financial Engineering Cure Cancer?: The Unabridged Version." SSRN: http://ssrn.com/abstract=2203203.
4. Federal Reserve Board of Governors. 2012. "Federal Reserve Statistical Release: Table H.15 (519) Selected Interest Rates." Washington, DC: Federal Reserve Board.
5. Fernandez, Jose-Maria, Roger M. Stein, and Andrew W. Lo. 2012. "Commercializing Biomedical Research Through Securitization Techniques." Nature Biotechnology 30: 964-75.
6. Huggett, Brady. 2012. "Biotech's Wellspring: A Survey of the Health of the Private Sector." Nature Biotechnology 30: 395-400.
7. Milken Institute. 2012. Fixes in Financing: Financial Innovation for Translational Research. Washington, DC: Milken Institute.
8. Nanda, Ramana, and Matthew Rhodes-Kropf. 2011. "Financing Risk and Innovation." Harvard Business School Working Paper No. 11-013.
9. National Venture Capital Association. 2011. National Venture Capital Association Yearbook 2011. New York: Thomson Reuters.
10. Papadopoulos, Stelios. 2011. "Profle: Stelios Papadopoulos." Nature Biotechnology 29: 184.
11. Paul, Steven M., Daniel S. Mytelka, Christopher T. Dunwiddie, Charles C. Persinger, Bernard H. Munos, Stacy R. Lindborg, and Aaron L. Schacht. 2010. "How to Improve R&D Productivity: The Pharmaceutical Industry's Grand Challenge." Nature Reviews Drug Discovery 9: 203-214.
12. Pisano, Gary P. 2006. Science Business: The Promise, the Reality, and the Future of Biotech. Boston: Harvard Business School Press.
13. Securities Industry and Financial Markets Association (SIFMA). 2012. "U.S. Key Stats." Washington, DC: SIFMA.
14. Thomas, David. 2012. "Oncology Clinical Trials-Secrets of Success." BIOTech-NOW, February 24.
15. Vasicek, Oldrich Alfons. 1987. Probability of Loss on Loan Portfolio. San Francisco: KMV Corporation.